{
  "pmcid": "8654268",
  "sha256": "7542299df2c86d9eb4f650e2a252a7bd866684c7528a3886054261bb3fd24ac9",
  "timestamp_utc": "2025-11-09T22:59:04.656014+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.346212121212123,
    "reading_ease": 18.80727272727276,
    "word_count": 240
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Mechanical Power and Postoperative Pulmonary Complications"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Adult patients undergoing major noncardiothoracic, nonintracranial surgery were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "Adult patients undergoing major noncardiothoracic, nonintracranial surgery were randomised"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either low tidal volume (6 ml/kg predicted body weight) or conventional tidal volume (10 ml/kg predicted body weight) ventilation"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of PPCs within the first seven postoperative days"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group allocation"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 1236 patients were randomised"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "1156 included in the final analysis using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Higher mechanical power was independently associated with increased risk of PPCs (OR 1.34, 95% CI 1.17 to 1.52; p < 0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ANZCTR: ACTRN12614000790640"
      },
      "Funding": {
        "score": 1,
        "evidence": "The study was funded by institutional sources"
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}